United Services Automobile Association Intellia Therapeutics, Inc. Transaction History

United Services Automobile Association

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 13, 2019	SELL	$11.39 - $27.13 $284,271 - $677,110	-24,958 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$25.78 - $32.6 $348,726 - $440,980	-13,527 Reduced 35.15%	24,958 $714,000
Q2 2018 Aug 10, 2018	SELL	$20.02 - $30.79 $8,068 - $12,408	-403 Reduced 1.04%	38,485 $1.05 Million
Q1 2018 May 14, 2018	SELL	$19.43 - $34.95 $44,106 - $79,336	-2,270 Reduced 5.52%	38,888 $820,000
Q4 2017 Feb 14, 2018	SELL	$17.39 - $31.12 $896,315 - $1.6 Million	-51,542 Reduced 55.6%	41,158 $791,000
Q3 2017 Nov 14, 2017	BUY	$15.16 - $25.75 $1.41 Million - $2.39 Million	92,700	92,700 $2.3 Million

314

91.5M

442K

880K

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $775M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

Stay updated on United Services Automobile Association with notifications on news.